Minerva Surgical (NASDAQ:UTRS) Trading Down 8.9%

Shares of Minerva Surgical, Inc. (NASDAQ:UTRS) dropped 8.9% on Wednesday . The stock traded as low as $0.51 and last traded at $0.51. Approximately 600 shares were traded during trading, a decline of 84% from the average daily volume of 3,772 shares. The stock had previously closed at $0.56.

Minerva Surgical Stock Performance

The company has a fifty day simple moving average of $0.61 and a two-hundred day simple moving average of $1.47. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.03 and a current ratio of 1.88.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in UTRS. Vanguard Group Inc. lifted its holdings in Minerva Surgical by 64.8% during the first quarter. Vanguard Group Inc. now owns 378,781 shares of the company’s stock worth $1,705,000 after acquiring an additional 148,915 shares in the last quarter. State Street Corp lifted its holdings in shares of Minerva Surgical by 950.6% in the second quarter. State Street Corp now owns 161,800 shares of the company’s stock valued at $41,000 after purchasing an additional 146,400 shares in the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Minerva Surgical by 284.7% in the second quarter. Geode Capital Management LLC now owns 128,749 shares of the company’s stock valued at $33,000 after purchasing an additional 95,284 shares in the last quarter.

About Minerva Surgical

Minerva Surgical, Inc, a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.